Pharmacoepidemiology applies epidemiological methods to study the use and effects of drugs in large populations. It provides essential data on drug safety, effectiveness, and patterns of utilization in real-world settings. By combining pharmacology and epidemiology, this field supports informed decision-making for healthcare policy, clinical guidelines, and risk management. Data sources include electronic health records, prescription databases, and patient registries. Current research focuses on evaluating long-term safety, comparative effectiveness, and rare adverse events. Pharmacoepidemiology also plays a crucial role in pharmacovigilance and health economics.
sub tracks:
Related Conferences:
World Congress on Pharmacology & Toxicology (WCPT) | International Conference on Clinical Pharmacology & Therapeutics (ICCPT) | Global Summit on Drug Discovery and Development (GSDDD) | European Conference on Toxicology & Applied Pharmacology (ECTAP) | International Symposium on Experimental and Clinical Toxicology (ISECT)
Related Associations:
International Union of Basic and Clinical Pharmacology (IUPHAR) | British Pharmacological Society (BPS) | American Society for Pharmacology and Experimental Therapeutics (ASPET) | European Society of Toxicology (EUROTOX) | Society of Toxicology (SOT) | Asia Pacific Association of Pharmacologists (APAP) | Federation of Asian Pharmacological Societies (FAPS) | International Society for the Study of Xenobiotics (ISSX)
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
